{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:41:40Z","timestamp":1793396500009,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-60098-3","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:02:08Z","timestamp":1725854528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Activated partial thromboplastin time-based clot waveform analysis: a potential for application in acute myocardial infarction and its complications"],"prefix":"10.1038","volume":"14","author":[{"given":"Chen Lin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Maverick","family":"Uy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Anne","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Hui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee How","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng Joo","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khung Keong","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"60098_CR1","unstructured":"WHO Global Health Observatory. Mortality and global health estimates [Internet]. [cited 2021 Aug 13]. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates"},{"issue":"134","key":"60098_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-134-3-200102060-00014","volume":"1","author":"U Rauch","year":"2001","unstructured":"Rauch, U. et al. Thrombus formation on atherosclerotic plaques: Pathogenesis and clinical consequences. Ann. Intern. Med. 1(134), 224\u2013238 (2001).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"60098_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1182\/asheducation-2011.1.51","volume":"2011","author":"ZS Kaplan","year":"2011","unstructured":"Kaplan, Z. S. & Jackson, S. P. The role of platelets in atherothrombosis. Hematology 2011(1), 51\u201361 (2011).","journal-title":"Hematology"},{"issue":"4","key":"60098_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/hrt.2004.034058","volume":"91","author":"Y Sato","year":"2005","unstructured":"Sato, Y. et al. Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart 91(4), 526\u2013530 (2005).","journal-title":"Heart"},{"issue":"12","key":"60098_CR5","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1182\/blood.V97.12.3721","volume":"97","author":"I Ott","year":"2001","unstructured":"Ott, I. et al. Regulation of monocyte procoagulant activity in acute myocardial infarction: Role of tissue factor and tissue factor pathway inhibitor-1. Blood 97(12), 3721\u20133726 (2001).","journal-title":"Blood"},{"issue":"5","key":"60098_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","volume":"33","author":"J Ma","year":"1999","unstructured":"Ma, J., Hennekens, C. H., Ridker, P. M. & Stampfer, M. J. A prospective study of fibrinogen and risk of myocardial infarction in the physicians\u2019 health study. J. Am. Coll. Cardiol. 33(5), 1347\u20131352 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"60098_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/01.ATV.0000079512.66448.1D","volume":"23","author":"G Luc","year":"2003","unstructured":"Luc, G. et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME Study. Arterioscler. Thromb. Vasc. Biol. 23(7), 1255\u20131261 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"60098_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-0609.2006.00656.x","volume":"77","author":"B Tanis","year":"2006","unstructured":"Tanis, B., Algra, A., van der Graaf, Y., Helmerhorst, F. & Rosendaal, F. Procoagulant factors and the risk of myocardial infarction in young women. Eur. J. Haematol. 77(1), 67\u201373 (2006).","journal-title":"Eur. J. Haematol."},{"issue":"13","key":"60098_CR9","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","volume":"108","author":"CJM Doggen","year":"2006","unstructured":"Doggen, C. J. M., Rosendaal, F. R. & Meijers, J. C. M. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 108(13), 4045\u20134051 (2006).","journal-title":"Blood"},{"issue":"11","key":"60098_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","volume":"97","author":"CJM Doggen","year":"1998","unstructured":"Doggen, C. J. M., Cats, V. M., Bertina, R. M. & Rosendaal, F. R. Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 97(11), 1037\u20131041 (1998).","journal-title":"Circulation"},{"key":"60098_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1538-7836.2010.04162.x","volume":"9","author":"M Smid","year":"2011","unstructured":"Smid, M. et al. Thrombin generation in patients with a first acute myocardial infarction. J. Thromb. Haemost. 9, 450\u2013456 (2011).","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"60098_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2141.2006.06021.x","volume":"133","author":"G Lowe","year":"2006","unstructured":"Lowe, G. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br. J. Haematol. 133(3), 232\u2013250 (2006).","journal-title":"Br. J. Haematol."},{"key":"60098_CR13","first-page":"75","volume":"13","author":"RC Franz","year":"1981","unstructured":"Franz, R. C. & Coetzee, W. J. The thrombelastographic diagnosis of hemostatic defects. Surg. Annu. 13, 75\u2013107 (1981).","journal-title":"Surg. Annu."},{"key":"60098_CR14","unstructured":"Chaudhary, R., Pagali, S., Bliden, K., Tantry, U. & Gurbel, P. Thrombin-Induced Platelet Fibrin Clot Strength Identified by Thromboelastography: A Potential Marker of Increased Thrombotic Risk in Older Adults with Coronary Artery Disease [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https:\/\/abstracts.isth.org\/abstract\/thrombin-induced-platelet-fibrin-clot-strength-identified-by-thromboelastography-a-potential-marker-of-increased-thrombotic-risk-in-older-adults-with-coronary-artery-disease\/. Accessed July 24, 2022."},{"issue":"2","key":"60098_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1538-7836.2006.01730.x","volume":"4","author":"T Matsumoto","year":"2006","unstructured":"Matsumoto, T. et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J. Thromb. Haemost. 4(2), 377\u2013384 (2006).","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 1","key":"60098_CR16","first-page":"S48","volume":"34","author":"T Siegemund","year":"2014","unstructured":"Siegemund, T., Scholz, U., Schobess, R. & Siegemund, A. Clot waveform analysis in patients with haemophilia A. Hamostaseologie 34(Suppl 1), S48-52 (2014).","journal-title":"Hamostaseologie"},{"issue":"1","key":"60098_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1365-2141.1997.1062972.x","volume":"98","author":"C Downey","year":"1997","unstructured":"Downey, C., Rashid, K. & Toh, C. H. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br. J. Haematol. 98(1), 68\u201373 (1997).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"60098_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12959-019-0201-0","volume":"17","author":"K Suzuki","year":"2019","unstructured":"Suzuki, K. et al. Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. Thromb. J. 17(1), 1\u20138 (2019).","journal-title":"Thromb. J."},{"issue":"6","key":"60098_CR19","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/01.CCM.0000217471.12799.1C","volume":"34","author":"N Chopin","year":"2006","unstructured":"Chopin, N. et al. Activated partial thromboplastin time waveform analysis: A new tool to detect infection?. Crit. Care Med. 34(6), 1654\u20131660 (2006).","journal-title":"Crit. Care Med."},{"key":"60098_CR20","doi-asserted-by":"crossref","unstructured":"Vuilliez, A., Floccard, B., Sobas, F., Chopin, N. & Allaouchiche, B. Le Flag A2: un drapeau rouge dans le sepsis? Rappel technique et int\u00e9r\u00eat comme marqueur du sepsis [The abnormal activated partial thromboplastin time biphasic waveform: a red flag in the sepsis? Technique and interest as marker of the sepsis]. Annales francaises d\u2019anesthesie et de reanimation. 26(3):259\u2013262 (2007). French.","DOI":"10.1016\/j.annfar.2006.11.013"},{"issue":"2","key":"60098_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.11613\/BM.2019.020710","volume":"29","author":"CW Tan","year":"2019","unstructured":"Tan, C. W. et al. Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism. Biochem. Med. 29(2), 385\u2013393 (2019).","journal-title":"Biochem. Med."},{"issue":"3","key":"60098_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/cclm-2017-0678","volume":"56","author":"M Ruberto","year":"2018","unstructured":"Ruberto, M. et al. The venous thromboembolic risk and the clot wave analysis: A useful relationship?. Clin. Chem. Lab. Med. 56(3), 448\u2013453 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"60098_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11239-020-02318-x","volume":"51","author":"BE Fan","year":"2021","unstructured":"Fan, B. E. et al. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J. Thromb. Thrombolysis 51(3), 663\u2013674 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"key":"60098_CR24","first-page":"1","volume":"14","author":"J Ichikawa","year":"2021","unstructured":"Ichikawa, J. et al. Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19. J. Thromb. Thrombolysis. 14, 1\u20135 (2021) (Epub 2021 Jul 14).","journal-title":"J. Thromb. Thrombolysis."},{"issue":"6","key":"60098_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ijlh.12724","volume":"39","author":"PO Sevenet","year":"2017","unstructured":"Sevenet, P. O. & Depasse, F. Clot waveform analysis: Where do we stand in 2017?. Int. J. Lab. Hematol. 39(6), 561\u2013568 (2017).","journal-title":"Int. J. Lab. Hematol."},{"issue":"22","key":"60098_CR26","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1161\/CIRCULATIONAHA.108.778837","volume":"118","author":"MY Chan","year":"2008","unstructured":"Chan, M. Y., Andreotti, F. & Becker, R. C. Hypercoagulable states in cardiovascular disease. Circulation 118(22), 2286\u20132297 (2008).","journal-title":"Circulation"},{"issue":"8","key":"60098_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133523","volume":"10","author":"A Maino","year":"2015","unstructured":"Maino, A., Rosendaal, F. R., Algra, A., Peyvandi, F. & Siegerink, B. Hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: A systematic review. PLoS ONE 10(8), e0133523 (2015).","journal-title":"PLoS ONE"},{"issue":"6","key":"60098_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066977","volume":"8","author":"M Smid","year":"2013","unstructured":"Smid, M. et al. Thrombin generation in the glasgow myocardial infarction study. PLoS ONE 8(6), e66977 (2013).","journal-title":"PLoS ONE"},{"issue":"7","key":"60098_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158355","volume":"11","author":"R Loeffen","year":"2016","unstructured":"Loeffen, R. et al. Factor XIa and thrombin generation are elevated in patients with acute coronary syndrome and predict recurrent cardiovascular events. PLoS ONE 11(7), e0158355 (2016).","journal-title":"PLoS ONE"},{"issue":"155","key":"60098_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.thromres.2017.04.021","volume":"1","author":"F Tosi","year":"2017","unstructured":"Tosi, F. et al. Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study. Thromb. Res. 1(155), 16\u201322 (2017).","journal-title":"Thromb. Res."},{"issue":"1","key":"60098_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/16078454.2022.2043573","volume":"27","author":"MA Cheong","year":"2022","unstructured":"Cheong, M. A. et al. A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin. Hematology 27(1), 337\u2013342 (2022).","journal-title":"Hematology"},{"issue":"5","key":"60098_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","volume":"21","author":"PW Kamphuisen","year":"2001","unstructured":"Kamphuisen, P. W., Eikenboom, J. C. J. & Bertina, R. M. Elevated factor VIII levels and the risk of thrombosis. Arterioscler. Thromb. Vasc. Biol. 21(5), 731\u2013738 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"14","key":"60098_CR33","first-page":"1799","volume":"294","author":"Fibrinogen Studies Collaboration","year":"2005","unstructured":"Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 294(14), 1799\u20131809 (2005).","journal-title":"JAMA"},{"issue":"11","key":"60098_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/000331978303401101","volume":"34","author":"N Cristal","year":"1983","unstructured":"Cristal, N., Slonim, A., Bar-Ilan, I. & Hart, A. Plasma fibrinogen levels and the clinical course of acute myocardial infarction. Angiology. 34(11), 693\u2013698 (1983).","journal-title":"Angiology."},{"key":"60098_CR35","doi-asserted-by":"crossref","unstructured":"Elad, B., Koren, O., Slim, W., Turgeman, Y., Avraham, G., Schwartz, N. et al. Thrombin generation\u2019s role in predicting coronary disease severity. PLoS ONE. 15(8) (2020).","DOI":"10.1371\/journal.pone.0237024"},{"issue":"4","key":"60098_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/03009734.2017.1407849","volume":"122","author":"C Christersson","year":"2018","unstructured":"Christersson, C., Lindahl, B., Berglund, L., Siegbahn, A. & Oldgren, J. The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients. Upsala J. Med. Sci. 122(4), 224\u2013233 (2018).","journal-title":"Upsala J. Med. Sci."},{"issue":"14","key":"60098_CR37","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/diagnostics13142447","volume":"13","author":"WH Wong","year":"2023","unstructured":"Wong, W. H. et al. Reagent effects on the activated partial thromboplastin time clot waveform analysis: A multi-centre study. Diagnostics (Basel) 13(14), 2447 (2023).","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"60098_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.trsl.2010.02.001","volume":"155","author":"WZ Abdullah","year":"2010","unstructured":"Abdullah, W. Z., Moufak, S. K., Yusof, Z., Mohamad, M. S. & Kamarul, I. M. Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. Transl. Res. 155(6), 315\u2013319 (2010).","journal-title":"Transl. Res."},{"issue":"1","key":"60098_CR39","first-page":"1","volume":"13","author":"MS Anvari","year":"2018","unstructured":"Anvari, M. S. et al. Coronary artery disease presentation and its association with shortened activated partial thromboplastin time. J. Tehran Univ. Heart Cent. 13(1), 1\u20135 (2018).","journal-title":"J. Tehran Univ. Heart Cent."},{"issue":"26","key":"60098_CR40","first-page":"1","volume":"30","author":"H Wada","year":"2020","unstructured":"Wada, H., Matsumoto, T., Ohishi, K., Shiraki, K. & Shimaoka, M. Update on the clot waveform analysis. Clin. Appl. Thromb. Hemost. 30(26), 1\u20138 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60098-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:09:22Z","timestamp":1734347362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["60098"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-60098-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20917"}}